Pages that link to "Q48604342"
Jump to navigation
Jump to search
The following pages link to Cognitive impact of anticholinergic medication in MS: Adding insult to injury? (Q48604342):
Displaying 3 items.
- Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. (Q47243953) (← links)
- Recommendations for cognitive screening and management in multiple sclerosis care (Q57285404) (← links)
- Temperature sensitivity in multiple sclerosis: An overview of its impact on sensory and cognitive symptoms (Q58127338) (← links)